Gregory Rasmussen
Physical Medicine & Rehabilitation · Layton, UTNPI 1295045326
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 52.5% of the total. 2025 is the largest year on record at $492, 2.4 times the $201 reported in 2021.
Across 91 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$914
- Nalu Medical, Inc.$88
- Collegium Pharmaceutical, Inc.$85
- Relievant Medsystems, Inc.$84
- Medtronic$73
- Boston Scientific$70
- plus $427 from 17 others
What the payments were for
- Food & beverage$1,741100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $914 |
| Nalu Medical, Inc. | 4 | $88 |
| Collegium Pharmaceutical, Inc. | 4 | $85 |
| Relievant Medsystems, Inc. | 3 | $84 |
| Medtronic | 4 | $73 |
| Boston Scientific | 4 | $70 |
| Nevro Corp. | 2 | $55 |
| Averitas Pharma Inc. | 2 | $54 |
| Innovation Technologies Inc | 1 | $44 |
| Amgen | 2 | $38 |
| Si-bone, Inc. | 2 | $31 |
| TELA Bio, Inc. | 1 | $29 |
| Saluda Medical Americas, Inc. | 1 | $26 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| ABC Home Medical Supply, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Pfizer | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| International Rehabilitative Sciences, Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Stimwave Technologies Incorporated | 1 | $12 |
How this compares
$1,741 in reported general payments places this provider in the 75th percentile of 117 physical medicine & rehabilitation providers in Utah.
See all physical medicine & rehabilitation providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $1,296 |
| Tramadol Hcl | 38 | $194 |
| Gabapentin | 21 | $137 |
| Diazepam | 14 | $17 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Layton
- Martin BertramLayton$5K
- Brian MorganLayton$1K
- Douglas ShepherdLayton$1K
- Dallin DemordauntLayton$516
- William BrandtLayton$369
- Scott AdelmanPark City$143K
- Judith GoochSlc$43K
- Colby BealSt George$25K
- Stephen AndersonBountiful$11K
- Timothy GrangeSalt Lake City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.